Results 161 to 170 of about 651,025 (323)
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy+12 more
wiley +1 more source
Does formal public transport serve the city well? The importance of semiformal transport for the accessibility in Medellín, Colombia. [PDF]
Stiller D+5 more
europepmc +1 more source
Degree of Water Swelling and Accessibility of PVA Fiber
Naomichi Takahashi, Kenji Onozato
openalex +2 more sources
Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen+6 more
wiley +1 more source
Spatial analysis of prehospital emergency medical services accessibility: a comparative evaluation of the GAUSS-probability two-step floating catchment area model in Handan City. [PDF]
Tian F+5 more
europepmc +1 more source
Methodology of determining the uncertainty in the accessible geothermal resource base of identified hydrothermal convection systems [PDF]
Manuel Nathenson
openalex +1 more source
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti+8 more
wiley +1 more source
Illuminating the path to more equitable access to urban parks. [PDF]
Zhang K+4 more
europepmc +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source